Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 20, 2018

Study Completion Date

December 20, 2018

Conditions

HypogonadismSevere Obesity

Interventions

DRUG

Anastrazole

BEHAVIORAL

weight loss

Trial Locations (1)

Michael E. DeBakey Veterans Affairs Medical Center, Houston

All Listed Sponsors

lead

Baylor College of Medicine

OTHER

NCT02959853 - Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot) | Biotech Hunter | Biotech Hunter